Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 7, 2010, Pages 909-915

  Houben, Rein M G J ^a,b   Glynn, J R ^a,b   Mallard, K ^a   Sichali, L ^b   Malema, S ^b   Fine, P E M ^a,b   French, N ^a,b   Crampin, A C ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KARONGA PREVENTION STUDY   (Malawi)

Author keywords

HIV; Latent M. tuberculosis infection; Molecular epidemiology; Re infection disease; Tuberculosis

Indexed keywords

BCG VACCINE; ISONIAZID;

ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FINGERPRINTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LATENT VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REINFECTION; SCAR; SEX RATIO; TUBERCULIN TEST; CLUSTER ANALYSIS; COMPLICATION; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; RECURRENT DISEASE; RISK FACTOR; TUBERCULOSIS;

CLUSTER ANALYSIS; DNA FINGERPRINTING; HIV INFECTIONS; HUMANS; MALAWI; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; RISK FACTORS; TUBERCULOSIS;

EID: 77953623297     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sutherland I, Svandova E, Radhakrishna S. The development of clinical tuberculosis following infection with tubercle bacilli. Tubercle 1982; 63: 255-268. (Pubitemid 13179232)
2. Vynnycky E, Fine P E. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997; 119: 183-201.
3. Mack U, Migliori G B, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
4. Corbett E L, Watt C J, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
5. Houben R M, Crampin A C, Mallard K, et al. HIV and the risk of tuberculosis due to recent transmission over 12 years in Karonga District, Malawi. Trans R Soc Trop Med Hyg 2009; 103: 1187-1189.
6. Houben R M G J, Crampin A C, Ndlovu R, et al. HIV increases the risk of TB due to recent infection, but the effect varies with age. Research in progress. London, UK: Royal Society of Tropical Medicine & Hygiene, 2008.
7. Styblo K. Epidemiology of tuberculosis, Selected Papers. Vol. 24. The Hague, The Netherlands: Royal Netherlands Tuberculosis Association (KNCV), 1991.
8. Canetti G, Sutherland I, Svandova E. Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis. Bull Int Union Tuberc 1972; 47: 116-134.
9. Ziegler J E, Edwards M L, Smith D W. Exogenous re-infection in experimental airborne tuberculosis. Tubercle 1985; 66: 121-128.
10. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161 (Suppl): S221-S247.
11. Cohn D L, O'Brien R J. The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries. Int J Tuberc Lung Dis 1998; 2: 16-26.
12. Fine P E, Bruce J, Ponnighaus J M, et al. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis 1999; 3: 962-975.
13. Rieder H L. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tubercle Lung Dis 1995; 76: 114-121.
14. National Statistics Office. Preliminary results 2008. Malawi Population and Housing Census. Zomba, Malawi: NSO, 2009.
15. Crampin A C, Glynn J R, Fine P E. What has Karonga taught us? Tuberculosis studied over three decades. Int J Tuberc Lung Dis 2009; 13: 153-164.
16. Fine P E, Sterne J A, Pönnighaus J M, Rees R J. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994; 344: 1245-1249.
17. van Embden J D, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409.
18. Glynn J R, Crampin A C, Ngwira B M, et al. Trends in tuberculosis and the influence of HIV infection in northern Malawi, 1988-2001. AIDS 2004; 18: 1459-1463.
19. Holm J. Development from tuberculosis infection to tuberculosis disease. TSRU Progress Report. The Hague, The Netherlands: KNCV, 1969.
20. Glynn J R, Bauer J, de Boer A S, et al. Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis 1999; 3: 1055-1060.
21. Glynn J R, Pönnighaus J, Crampin A C, et al. The development of the HIV epidemic in Karonga District, Malawi. AIDS 2001; 15: 2025-2029.
22. Crampin A C, Glynn J R, Floyd S, et al. Tuberculosis and gender: exploring the patterns in a case control study in Malawi. Int J Tuberc Lung Dis 2004; 8: 194-203.
23. Frieden T R, Woodley C L, Crawford J T, Lew D, Dooley S M. The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tubercle Lung Dis 1996; 77: 407-413.
24. Chan-Yeung M, Kam K M, Leung C C, et al. Population-based prospective molecular and conventional epidemiological study of tuberculosis in Hong Kong. Respirology 2006; 11: 442-448.
25. Wilkinson D, Pillay M, Crump J, Lombard C, Davies G R, Sturm A W. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health 1997; 2: 747-753.
26. Houben R M, Glynn J R. A systematic review and meta-analysis of molecular epidemiological studies of tuberculosis: development of a new tool to aid interpretation. Trop Med Int Health 2009; 14: 892-909.
27. Braden C R, Templeton G L, Cave M D, et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997; 175: 1446-1452.
28. World Health Organization. Three I's Meeting; Intensified case finding (IC), isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV. Geneva, Switzerland: WHO, 2008.
29. Escombe A R, Oeser C C, Gilman R H, et al. Natural ventilation for the prevention of airborne contagion. PLoS Med 2007; 4(2): e68.
30. Aït-Khaled N, Alarcon E, Bissell K, et al. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis 2009; 13: 927-935.
31. Crampin A C, Mwaungulu J N, Mwaungulu F D, et al. Recurrent TB: relapse or reinfection? The effect of HIV in general population cohort in Malawi. AIDS 2010; 24: 417-426.
32. Sonnenberg P, Murray J, Glynn J R, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358: 1687-1693.